Increasing knowledge about how to manage the risks of gene therapy
is set to usher in a new era in disease therapies, with the
prospect of developing treatments in treating rare, inherited, or
life-threatening diseases very real.
Researchers have shown how protein synthesis is targeted to certain
regions of a cell, a process crucial for the cellular motility,
which could form a basis for producing a drug that could force
tumour cells to express this protein,...
Sun Microsystems have strengthened the fight against drug
counterfeiting by launching a unique RFID software package tailored
to the specific needs of the pharmaceutical industry.
Global packaging provider Rexam is expanding its US business,
announcing this week that it is set to acquire plastic packaging
firm Precise Technology - a move that will expand its capabilities
in the growing pharmaceutical packaging...
Patheon has received the 2005 Contract Manufacturing Company of the
Year Award from consultancy firm Frost & Sullivan, in
recognition of its customer service and innovative market growth
strategies.
The surge in vaccines against influenza has surprised Governments
across the world, with the stark admission that demand was
unforeseen. Avian flu, which has emerged as a real threat to
humans, has not only have added to the danger...
New legislation has given UK company Accentus the green light to
use its novel predictive crystallisation technology to discover and
market variations of patented drugs without infringing the original
patent.
GenoID has announced a breakthrough in human papillomavirus (HPV)
testing with the first ever laboratory test kit that uses a
real-time polymerase chain reaction (real-time PCR) method to
detect all virus variants that cause cervical...
The need to analyse voluminous data is set to create a wealth of
opportunities for bioinformatics in which systems integration
capabilities are predicted to boost uptake of bioinformatics and
clinical informatics in drug discovery...
Pfizer and Incyte have entered a collaborative research and license
agreement for the development and commercialisation of CCR2
antagonists - an emerging class of drug that aims to serve an unmet
need in the treatment of rheumatoid...
Scientists have noted that stimulating brain cell receptors for
certain hormone-like chemicals in brain cells can protect them from
a compound linked to brain cell death and Alzheimer's disease (AD).
Researchers have combined nanotechnology with biochemistry to
create synthetic membranes that, for the first time, enable direct
control of signalling activity in living T cells from the immune
system, which could lead to better development...
A new class of chiral stationary phases (CSPs) for analytical and
preparative-scale high performance liquid chromatography (HPLC),
has been launched by ZirChrom Separations, which further enhances
HPLC as a method of choice for chiral...
Avecia spin-off, Reaxa, has announced that Umicore has taken a 21
per cent stake in a move that underlines Reaxa's business strategy
in looking at joint R&D, new product development and toll
manufacturing agreements.
In the second part of a special report, In-PharmaTechnologist has
taken a closer look at the Pharmaceutical Fine Chemicals Business
of Clariant, which made a series of announcements on new
investments in facilities in Europe and the...
Superfos has reported positive third quarter results after a
troubled start to the year. The company attributes the turnaround
to declining raw material prices and growth in European business
sales.
A European parliament vote on the REACH chemicals legislation last
week struck a balance between health, the environment and industry
after months of intense debate.
Solvias debuted its new 80-member ligand kit at CPhI 2005, offering
manufacturers increased flexibility in active pharmaceutical
ingredient (API) development and manufacturing.
US company Flavorx will make good tasting medicine a reality when
it expands its blockbuster medication flavours into the UK pharmacy
market, after a continuous stream of consumer and business
interest.
Degussa used CPhI in Madrid to preview its new flow distributor,
which reduces the time it takes manufacturers to remove unwanted
transition metals from active pharmaceutical ingredients (APIs), by
eliminating the filtration step.
Generex has escalated manufacturing capabilities to meet expected
demand for the first ever commercially available non-injectable
insulin product, to be launched in Ecuador at the end of the month.
Chemical company Lanxess, release its third quarter results that
show restructuring strategy is bearing fruit, with sales up and the
reduction of net financial debt that is supported by strong growth
in the chemical industry.
The Pharmaceutical Fine Chemicals Business of Clariant took the
opportunity to review new developments at the CPhI Expo in Madrid,
Spain, making announcements on new investments in facilities in
Europe and the US as well as new business...
Millipore Corporation today announced two tangential flow
filtration (TFF) products that allow researchers to efficiently
purify large volumes of protein-containing solutions that
accelerate drug screening and improve sample preparation.
Vasogen announced preclinical data this week, demonstrating the
ability of its lead drug candidate to modulate key signalling
pathways associated with inflammation, demonstrating therapeutic
potential in a range of neurological disorders.
Schering-Plough has entered into an agreement with Oncomethylome
Sciences (OMS), which allows the pharma giants to use OMS
Pharmacogenomic technology to study MGMT methylation status in
brain cancer patients.
The Association of the British Pharmaceutial Industry (ABPI) has
revealed a new code of practice for the pharmaceutical industry,
with an emphasis on patient safety especially material detailing
information about reporting adverse...
German specialty chemicals group, H&R Wasag, increased its
sales and earnings in the third quarter of this year, helped by its
in-house refinery operations that allow it to counter the steady
rise in costs arising from crude oil...
Specialty chemical company Avecia featured prominently at the
recent CPhI Expo in Madrid, announcing investments and activity,
which hint at the business of custom synthesis of APIs and advanced
intermediates coming back into favour.
Sigma-Aldrich Fine Chemicals (SAFC) Biosciences chose the CPhI Expo
in Madrid to announce a series of updates concerning company
activity. The custom manufacturing group is currently undergoing
construction of a new US facility aimed...
Catch-up legislation from the EU has swept away the handicap on
European generics companies, allowing them to research copycat
drugs before patent expiry.
Drug development services company, Aptuit, has finalised a deal to
acquire InfoPro Solutions, which adds informatics services to
Aptuit's portfolio, as well as the Clinicopia Suite, which enables
customer access to drug development...
Kreatech Biotechnology launches its latest small RNA kit that
targets microRNA and siRNA arrays that directly labels any and all
sizes of naturally occurring nucleic acids without the need of
enzymes.
According to a recent report, analytic separation technology will
continue to evolve as limitations are addressed and standards grow
even more rigorous, as market drivers such as quality control,
instrument design, and software in...
A group of researchers have found that FLT-1 - a molecule
implicated in blood vessel growth - is necessary for the escape of
the leukaemia cells from the bone marrow (BM), suggesting that
blocking of this molecule pharmaceutically...
TorreyPines Therapeutics has initiated a phase I clinical trial for
its first-in-class compound, which claims to offer a non-opioid,
non-vascular approach to the management of severe pain.
Innovative laboratory technology that produces a sharper picture of
the nano-machine that translates genetic program into proteins
gives a unique insight into how some types of antibiotics work
leading to the design of better ones.
Pall Corporation has revealed a unique approach for speeding
vaccine production, which could provide a solution to the
potentially huge demand for vaccines by governments and
pharmaceutical manufacturers in response to the avian flu...
Pain Therapeutics and King Pharmaceuticals have entered into an
alliance to develop and commercialise Remoxy in an alliance worth
at least $400 million (€342 million). The deal positions the
abuse-resistant opioid painkiller as a...
Pliva released its financial results for the first nine months of
2005, which revealed a net loss of $34 million, as the drug maker
tries to recover from its loss-making drug launch in the US. This
is despite posting higher revenues...
Coremed has introduced its proprietary drug-delivery platform
technology that improves absorption of certain proteins and
macromolecules such as insulin within the gastrointestinal tract.
Last month, In-PharmaTechnologist.com reported on
Cargill-Cerestar's plans to unveil a new excipient at CPhI which is
developed on the back of a directly compressible excipient platform
allowing tablets to be produced using lower...
Dr. Reddy's Laboratories (DRL) has signed a definitive agreement to
acquire Roche's Mexican API business, in a move to drive the next
wave of growth in its custom pharmaceutical services (CPS)
business.
Cook Pharmica will be the first contract manufacturer to offer live
webcam services, an innovation that will enable both customers and
regulatory agencies to view production as it occurs.
Croda unveiled its new range of Super Refined PEG and Super Refined
Oleic Acid drug delivery excipients, claimed to enhance active
pharmaceutical ingredient (API) and formulation stability.
A simpler and more cost-effective way of obtaining high yields of
antibody fragments, which are used for research, diagnostic and
therapeutic applications may be possible after a deal was agreed to
produce the fragments in research...
Doctors and cancer researchers have pleaded with EU politicians to
support a strong REACH chemicals regulation in order to halt an
increase in cancer rates, congenital malformations and asthma.
Foss has introduced the latest in its NIRSystems analyser range,
featuring the company's XDS near-infrared (NIR) technology, for
improved analytical performance in harsh industrial manufacturing
environments.
Sophion Bioscience and Physio-Tech have signed an agreement in
which Physio-Tech will become the exclusive distributor of Qpatch
16 systems in Japan, signifying its introduction into the Asian
market.
A small molecule drug, which has been developed to treat solid
tumour and haematological cancer, has entered an Investigational
New Drug (IND) application that represents the emergence of aurora
kinase inhibitors as a viable cancer...